Applied Therapeutics, Inc. Deferred Costs, Current
Applied Therapeutics, Inc. had Deferred Costs, Current of $1.45 million as of 2019-03-31, per its 10-Q filed 2019-06-21.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2020-03-13
- 2019-03-31: Deferred Costs, Current $1.45M.
- 2018-12-31: Deferred Costs, Current $310.00K.
| Period end | Deferred Costs, Current |
|---|---|
| 2019-03-31 | $1.45M 10-Q · filed 2019-06-21 |
| 2018-12-31 | $310.00K 10-K · filed 2020-03-13 |